CPTH6 hydrobromide
Based on 1 Customer Validation
CPTH6 hydrobromide is a thiazole derivative which activates apoptotic program and increases autophagic features in human acute myeloid leukemia cell lines. CPTH6 can be used for cancer research.
For research use only. We do not sell to patients.
- Purity : 98.02%
- CAS No.: 2321332-57-2
- Formula: C15H17BrClN3S
- Molecular Weight:386.74
-
Storage:
-20°C, sealed storage, away from moisture
* In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture)
Biological Activity
Description
In Vitro
Chemical Information
-
CAS No. 2321332-57-2
-
Appearance Solid
-
Molecular Weight 386.74
-
Formula C15H17BrClN3S
-
Color White to off-white
-
SMILES
ClC1=CC=C(C2=CSC(N/N=C3CCC(C/3)C)=N2)C=C1.Br
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
-20°C, sealed storage, away from moisture
* In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture)
Solvent & Solubility
In Vitro:
DMSO : 66.67 mg/mL (172.39 mM; ultrasonic and warming and heat to 60°C; Hygroscopic DMSO has a significant impact on the solubility of product, please use newly opened DMSO)
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture). When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture). When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
Protocols
-
Apoptosis
Apoptosis, also called programmed cell death, is generally characterized by distinct morphological characteristics.
-
Autophagy
Autophagy is a process in which eukaryotic cells use lysosomes to degrade their own cytoplasmic proteins and damaged organelles under the regulation of autophagy related gene (Atg). Microtubule-associated proteins light chain 3 (LC3) is recognized as autophagy marker, which transfers from cytoplasmic LC3 (LC3-I) to membrane type (LC3-II). LC3-II/I ratio could be detected by Western Blot and fluorescence microscopy.
-
Apoptosis Solutions
Apoptosis is a regulated, generally non-lytic cell-death pathway that removes unwanted, damaged, infected, or abnormal cells through coordinated morphological changes, caspase activation, DNA fragmentation, and membrane remodeling. The intrinsic apoptosis pathway is controlled mainly by mitochondrial outer membrane permeabilization, BCL-2 family proteins, cytochrome c release, apoptosome formation, caspase-9 activation, and downstream executioner caspase-3/7 activation. The extrinsic apoptosis pathway is initiated by death receptors such as Fas, TNFR, and TRAIL receptors, which recruit adaptor proteins and activate caspase-8 before engaging executioner caspases or mitochondrial amplification through BID cleavage. Apoptosis is linked to many phenotypes, including cancer cell killing, tissue homeostasis, immune regulation, neurodegeneration, infection response, and treatment-induced cytotoxicity; unresolved questions include how apoptosis interacts with necroptosis, pyroptosis, ferroptos
Purity & Documentation
-
Data Sheet (269 KB)
-
SDS (252 KB)
- English - EN (252 KB)
- Français - FR (252 KB)
- Deutsch - DE (252 KB)
- Norwegian - NO (252 KB)
- Español - ES (252 KB)
- Swedish - SV (252 KB)
- Italian - IT (252 KB)
- Korean - KR (252 KB)
- Portuguese - PT (252 KB)
-
Handling Instructions (2659 KB)
References
Complete Stock Solution Preparation Table
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture). When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
| Optional Solvent | Concentration Solvent Mass | 1 mg | 5 mg | 10 mg | 25 mg |
|---|---|---|---|---|---|
| DMSO | 1 mM | 2.5857 mL | 12.9286 mL | 25.8572 mL | 64.6429 mL |
| 5 mM | 0.5171 mL | 2.5857 mL | 5.1714 mL | 12.9286 mL | |
| 10 mM | 0.2586 mL | 1.2929 mL | 2.5857 mL | 6.4643 mL | |
| 15 mM | 0.1724 mL | 0.8619 mL | 1.7238 mL | 4.3095 mL | |
| 20 mM | 0.1293 mL | 0.6464 mL | 1.2929 mL | 3.2321 mL | |
| 25 mM | 0.1034 mL | 0.5171 mL | 1.0343 mL | 2.5857 mL | |
| 30 mM | 0.0862 mL | 0.4310 mL | 0.8619 mL | 2.1548 mL | |
| 40 mM | 0.0646 mL | 0.3232 mL | 0.6464 mL | 1.6161 mL | |
| 50 mM | 0.0517 mL | 0.2586 mL | 0.5171 mL | 1.2929 mL | |
| 60 mM | 0.0431 mL | 0.2155 mL | 0.4310 mL | 1.0774 mL | |
| 80 mM | 0.0323 mL | 0.1616 mL | 0.3232 mL | 0.8080 mL | |
| 100 mM | 0.0259 mL | 0.1293 mL | 0.2586 mL | 0.6464 mL |